These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32143585)

  • 1. Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease.
    Rivero J; Rodríguez F; Soto V; Macedo E; Chawla LS; Mehta RL; Vaingankar S; Garimella PS; Garza C; Madero M
    BMC Nephrol; 2020 Mar; 21(1):87. PubMed ID: 32143585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation.
    Udomkarnjananun S; Townamchai N; Iampenkhae K; Petchlorlian A; Srisawat N; Katavetin P; Sutherasan M; Santingamkun A; Praditpornsilpa K; Eiam-Ong S; Avihingsanon Y
    Nephron; 2019; 141(4):236-248. PubMed ID: 30636249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial).
    Lumlertgul N; Peerapornratana S; Trakarnvanich T; Pongsittisak W; Surasit K; Chuasuwan A; Tankee P; Tiranathanagul K; Praditpornsilpa K; Tungsanga K; Eiam-Ong S; Kellum JA; Srisawat N;
    Crit Care; 2018 Apr; 22(1):101. PubMed ID: 29673370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
    Koyner JL; Davison DL; Brasha-Mitchell E; Chalikonda DM; Arthur JM; Shaw AD; Tumlin JA; Trevino SA; Bennett MR; Kimmel PL; Seneff MG; Chawla LS
    J Am Soc Nephrol; 2015 Aug; 26(8):2023-31. PubMed ID: 25655065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in renal responses to furosemide.
    Chun TY; Bankir L; Eckert GJ; Bichet DG; Saha C; Zaidi SA; Wagner MA; Pratt JH
    Hypertension; 2008 Aug; 52(2):241-8. PubMed ID: 18606909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Shimizu M; Furuichi K; Wada T
    Nephrol Dial Transplant; 2019 Jul; 34(7):1182-1188. PubMed ID: 29788462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists.
    Verdalles U; Goicoechea M; García de Vinuesa S; Torres E; Hernández A; Verde E; Pérez de José A; Luño J
    Nefrologia (Engl Ed); 2020; 40(1):65-73. PubMed ID: 31451203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers.
    Dhayat NA; Gradwell MW; Pathare G; Anderegg M; Schneider L; Luethi D; Mattmann C; Moe OW; Vogt B; Fuster DG
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1507-1517. PubMed ID: 28775126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Furosemide Stress Test in Renal Injury Prognosis.
    Coca A; Aller C; Reinaldo Sánchez J; Valencia AL; Bustamante-Munguira E; Bustamante-Munguira J
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury.
    Chawla LS; Davison DL; Brasha-Mitchell E; Koyner JL; Arthur JM; Shaw AD; Tumlin JA; Trevino SA; Kimmel PL; Seneff MG
    Crit Care; 2013 Sep; 17(5):R207. PubMed ID: 24053972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
    Mose FH; Jörgensen AN; Vrist MH; Ekelöf NP; Pedersen EB; Bech JN
    BMC Nephrol; 2019 Jun; 20(1):200. PubMed ID: 31159750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.
    Núñez J; Llàcer P; García-Blas S; Bonanad C; Ventura S; Núñez JM; Sánchez R; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Chamorro C; Bodi V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Rodríguez E; Mollar A; Palau P; Bosch MJ; Bertomeu-González V; Lupón J; Navarro J; Chorro FJ; Górriz JL; Sanchis J; Voors AA; Bayés-Genís A
    Am J Med; 2020 Mar; 133(3):370-380.e4. PubMed ID: 31422111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
    Huang A; Luethi N; Mårtensson J; Bellomo R; Cioccari L
    Crit Care Resusc; 2017 Jun; 19(2):142-149. PubMed ID: 28651510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation.
    McMahon BA; Koyner JL; Novick T; Menez S; Moran RA; Lonze BE; Desai N; Alasfar S; Borja M; Merritt WT; Ariyo P; Chawla LS; Kraus E
    Biomarkers; 2018 Feb; 23(1):61-69. PubMed ID: 29034718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.
    Zewinger S; Rauen T; Rudnicki M; Federico G; Wagner M; Triem S; Schunk SJ; Petrakis I; Schmit D; Wagenpfeil S; Heine GH; Mayer G; Floege J; Fliser D; Gröne HJ; Speer T
    J Am Soc Nephrol; 2018 Nov; 29(11):2722-2733. PubMed ID: 30279273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
    Dini FL; Ghio S; Klersy C; Rossi A; Simioniuc A; Scelsi L; Genta FT; Cicoira M; Tavazzi L; Temporelli PL
    Int J Clin Pract; 2013 Jul; 67(7):656-64. PubMed ID: 23758444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
    Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
    Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of a Morphometric Evaluation for Chronic Changes on All Diagnostic Native Kidney Biopsies.
    Denic A; Bogojevic M; Mullan AF; Sabov M; Asghar MS; Sethi S; Smith ML; Fervenza FC; Glassock RJ; Hommos MS; Rule AD
    J Am Soc Nephrol; 2022 Oct; 33(10):1927-1941. PubMed ID: 35922132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubulointerstitial Fibrosis of Living Donor Kidneys Associates with Urinary Monocyte Chemoattractant Protein 1.
    Wang X; Lieske JC; Alexander MP; Jayachandran M; Denic A; Mathew J; Lerman LO; Kremers WK; Larson JJ; Rule AD
    Am J Nephrol; 2016; 43(6):454-9. PubMed ID: 27288357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.